Discussion on Unique Drug Toxicities and Key Takeaways for Acute Lymphoblastic Leukemia

This chapter delves into the specific toxicities linked to various medications used in Acute Lymphoblastic Leukemia treatment, like thrombosis and pancreatitis with asparaginase, cytokine release syndrome with blematumumab, and liver veno-occlusive disease with inotuzumab. It also emphasizes important insights for managing ALL, such as treatment approaches, immunophenotype factors, and targeted therapy applications.